|
GO term |
P-value |
FDR |
Biological processes |
small molecule catabolic process |
0 |
0 |
|
organic acid biosynthetic process |
6.55E-14 |
2.78E-11 |
|
organic hydroxy compound metabolic process |
3.20E-10 |
9.06E-8 |
|
cellular amino acid metabolic process |
4.93E-10 |
1.05E-7 |
|
generation of precursor metabolites and energy |
6.84E-10 |
1.16E-7 |
|
fatty acid derivative metabolic process |
3.62E-9 |
5.12E-7 |
|
monosaccharide metabolic process |
5.46E-9 |
6.63E-7 |
|
nucleoside phosphate biosynthetic process |
1.17E-8 |
0.000001 |
|
ribonucleotide metabolic process |
1.26E-8 |
0.000001 |
|
fatty acid metabolic process |
2.06E-8 |
0.000002 |
Cellular component |
mitochondrial matrix |
0.000070 |
0.012090 |
|
ficolin-1-rich granule |
0.000265 |
0.022800 |
|
myelin sheath |
0.000774 |
0.044374 |
Molecular function |
cofactor binding |
6.66E-16 |
1.88E-13 |
|
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen |
7.64E-14 |
1.08E-11 |
|
lyase activity |
1.11E-11 |
1.04E-9 |
|
organic acid binding |
9.99E-9 |
6.93E-7 |
|
iron ion binding |
1.23E-8 |
6.93E-7 |
|
monooxygenase activity |
1.75E-8 |
8.24E-7 |
|
transferase activity, transferring glycosyl groups |
4.15E-8 |
0.000002 |
|
vitamin binding |
5.28E-8 |
0.000002 |
|
oxidoreductase activity, acting on the aldehyde or oxo group of donors |
0.000003 |
0.000084 |
|
oxidoreductase activity, acting on CH-OH group of donors |
0.000003 |
0.000095 |
KEGG pathway |
metabolic pathways |
0 |
0 |
|
drug metabolism |
2.43E-12 |
3.71E-10 |
|
retinol metabolism |
3.41E-12 |
3.71E-10 |
|
chemical carcinogenesis |
6.20E-11 |
3.62E-9 |
|
purine metabolism |
6.67E-11 |
3.62E-9 |
|
porphyrin and chlorophyll metabolism |
1.24E-9 |
5.76E-8 |
|
steroid hormone biosynthesis |
3.52E-9 |
1.43E-7 |
|
metabolism of xenobiotics by cytochrome P450 |
3.97E-9 |
1.44E-7 |
|
carbon metabolism |
6.20E-8 |
0.000002 |